Skip to content

Effect of Mindful Eating on Body Mass Index in Obese Adolescents

Effect of Mindful Eating on Body Mass Index and Cardiovascular Risk Markers in Obese Adolescents: A Pilot Randomized Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01764113
Enrollment
21
Registered
2013-01-09
Start date
2012-12-31
Completion date
2013-12-31
Last updated
2014-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Obesity

Keywords

Obesity, Adolescence, Mindful Eating

Brief summary

This study is designed to study the effect of a family based mindfulness training program with special focus on diet and nutrition on weight and cardiovascular risk markers in obese adolescents.

Detailed description

40 obese adolescents would be randomized into either a mindfulness based behavioral modification program or standard dietary counseling. At least one parent would be expected to attend the counseling sessions. Patients would be followed for a period of 6 months. Anthropometric parameters, questionaiires relating to quality of life and blood tests would be drawn at baseline and and at 6 months.

Interventions

BEHAVIORALMindful Eating

Subjects and their parents will receive mindful eating based behavioral modification program over multiple sessions

BEHAVIORALStandard dietary counselling

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* BMI at or greater than the 95th percentile for age and gender

Design outcomes

Primary

MeasureTime frameDescription
Body Mass IndexBaseline and 6 monthsBody Mass Index would be calculated at baseline, at 3 months and at 6 months

Secondary

MeasureTime frameDescription
Quality of LifeBaseline and 6 monthsWell validated questionnaires of quality of life would be assessed at baseline, at 3 months and at 6 months.

Other

MeasureTime frame
Fasting glucose6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026